Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:20 PM
Ignite Modification Date:
2025-12-24 @ 10:20 PM
NCT ID:
NCT07122635
Eligibility Criteria:
Inclusion Criteria:
* Patients undergoing phacoemulsification surgery with IOL implantation
* Diagnosis with grade 1, grade 2 or grade 3 dry eye one week after the surgery according to DEWS 2007 classification and Sullivan's severity grading scheme
Exclusion Criteria:
* Patients with grade 3 or 4 dry eye before phaco surgery
* Phaco surgery with complications during or after surgery
* Patients with other eye surgeries within 6 months before phaco surgery
* Patients who are using other eye drops before phaco surgery, except artificial tears
* Patients with acute eye infections
* Patients who do not return for follow-up appointments
* Patients who do not comply with treatment
* Patients having allergy with diquafosol 3%
* Patients having side effects with diquafosol 3% and do not want to continue using the drug
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT07122635
Study Brief:
Protocol Section:
NCT07122635